Where does Salk Institute for Biological Studies rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Salk Institute for Biological Studies ranks #3,406 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Salk Institute for Biological Studies hold?

Salk Institute for Biological Studies holds 109 US utility patents granted between 2015 and 2025, spanning 21 technology areas.

What is Salk Institute for Biological Studies's Innovation Score?

Salk Institute for Biological Studies has an Innovation Score of 48.5 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Salk Institute for Biological Studies focus on?

Salk Institute for Biological Studies's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 60 patents, ranking #287 of 6,058 assignees active in that subclass. Grants appear in 21 CPC subclasses total.

Is Salk Institute for Biological Studies's patent grant rate increasing or decreasing?

Salk Institute for Biological Studies's recent grant velocity is +19% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Salk Institute for Biological Studies's patents?

Salk Institute for Biological Studies's patents average 20.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Salk Institute for Biological Studies patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Salk Institute for Biological Studies

USPTO PatentsView assignee record - 109 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Salk ranks #3,406 of 49,997 tracked US assignees by granted-patent volume, with 109 patents across 21 technology areas.

#3,406
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.5/100): 20.6
avg claims per patent: +19%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3406 · US Corporation #3,406 · 109 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 109 grants
TOP-DECILE #3,406/49,997
PHOTO-FINISH SIG Technology
CPC-FOCUS A61P · 21 areas
INNOV-PAR 48.5/100
CLAIMS-DENSE 20.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +19% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: SIG Technology AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Salk’s 48.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.2 pts (33%) Velocity 3.7 pts (8%) Breadth 16.2 pts (33%) Claim depth 12.4 pts (26%)

Qualcomm Incorporated · highest

85
MCP IP · near

49
Mitsubishi Heavy… · near

49
Paul Wurth · near

49
Salk Institute for… · this assignee

49
Sekisui Plastics · near

49
3D Lighting… · lowest

7

What this shows Salk's Innovation Score is 48.5/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Salk?

Each dot is one of Salk’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Salk’s own 20.6 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Salk vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Salk's grants concentrate

Salk Institute for Biological Studies is a focused PatentsView assignee: 21 CPC subclasses with 55% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (17 grants) versus a trough of 4 in 2024. By volume, Salk sits between SIG Technology AG and Toshiba Digital Solutions Corporation.

Salk's three-year grant acceleration

From 2019–2021 to 2022–2024, Salk Institute for Biological Studies moved from 45 to 25 grants (0.56x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,557. See the growth leaderboard.

SIG Technology

109
Silgan Dispensing…

109
Skype

109
Stepan

109
Storedot

109
TEL Hashomer Medi…

109
The Stanley Works…

109
Toshiba Digital S…

109
Salk Institute fo… ◀

109

What this shows Salk holds 109 patents at rank #3,412, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Salk

By rank, the assignees closest to #3,412 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Salk's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Salk, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Salk ranks #287 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Mitsubishi Heavy Industries Engineering, Ltd. 49 MCP IP, LLC 49 Sekisui Plastics Co., Ltd. 49 Paul Wurth S.A. 49

Similar claim depth

Nearest assignees by average claims per patent (20.6 here).

MS Technologies 20.6 avg Eagle Harbor Technologies, Inc. 20.6 avg Indigo Ag, Inc. 20.6 avg Trax Technology Solutions Pte Ltd. 20.6 avg

Salk's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Salk Institute for Biological Studies patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	10.1%
2016	5	4.6%
2017	5	4.6%
2018	12	11.0%
2019	14	12.8%
2020	17	15.6%
2021	14	12.8%
2022	12	11.0%
2023	9	8.3%
2024	4	3.7%
2025partial year	6	5.5%

Which technologies does Salk Institute for Biological Studies patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 60

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 57

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 54

C07K - Peptides 32

C07D - Heterocyclic Compounds 20

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 17

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 15

C07C - Acyclic OR Carbocyclic Compounds 12

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

C12Y - Enzymes 9

A61B - DIAGNOSIS; SURGERY; Identification 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

Top 15 of 21 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Salk Institute for Biological Studies's patent record in context - here's where to go next.

Salk Institute for Biological Studies's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 55% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,406 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Salk Institute for Biological Studies against SIG Technology AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.